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ABSTRACT In this study we report on the developmental
and regional expression oftwo brain-specific isoforms of tropo-
myosin, TMBr-1 and TMBr-3, that are generated from the rat
a-tropomyosin gene via the use of alternative promoters and
alternative RNA splicing. Western blot analysis using an
exon-specific peptide polyclonal antibody revealed that the two
isoforms are differentially expressed in development with
TMBr-3 appearing in the embryonic brain at 16 days of
gestation, followed by the expression of TMBr-1 at 20 days
after birth. TMBr-3 was detected in all brain regions examined,
whereas TMBr-1 was detected predominantly in brain areas
that derive from the prosencephalon. Immunocytochemical
studies on mixed primary cultures made from rat embryonic
midbrain indicate that expression of the brain-specific epitope
is restricted to neurons. The developmental pattern and neu-
ronal localization of these forms of tropomyosin suggest that
these isoforms have a specialized role in the development and
plasticity of the nervous system.
Due to their function as conductors ofinformation in a mostly
vectorial manner, neurons differ significantly from other cell
types in size and geometry. Their size and shape are reflected
in the neuronal cytoskeleton (1) composed of a unique set of
structural proteins, such as neurofilaments, and a variety of
neuron-specific actin binding proteins, such as brain-specific
isoforms of myosin (2), spectrin (3), and tropomyosin (TM)
(4). The process of modifying, strengthening, or eliminating
synaptic connections both during and well after embryonic
development has ended is now hypothesized to be the
mechanism underlying such dynamic processes as learning
and memory (5-8). Thus, there is a potential requirement for
a changing repertoire of unique neuronal cytoskeletal ele-
ments that confer differential capabilities upon the neuron at
various times. Structural proteins unique to neurons are
generated by several different mechanisms. Some of these,
such as the neurofilament triplet (9), are transcribed from
different genes. Other isoforms are created by alternative
splicing of a single pre-mRNA, an important mechanism to
generate multiple isoforms from one gene (4, 10-16).
TMs are a group of actin-binding proteins that are ex-
pressed in most eukaryotic cells. TMs are encoded by
multiple genes, but diversity is also generated by alternative
RNA splicing (for a review, see ref. 17). Whereas TM
functions in skeletal and cardiac muscles in association with
the troponin complex to regulate the calcium-sensitive actin
and myosin interaction, the biological functions of TM in
nonmuscle and smooth muscle cells are not yet understood
(18). Since nonmuscle and smooth muscle cells are devoid of
a troponin complex, they likely have a distinct function
compared to TMs of skeletal and cardiac muscle.
The rat a-TM gene expresses at least nine isoforms (17),
including three isoforms in the rat brain, which were named
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
TMBr-1, TMBr-2, and TMBr-3, and are 281, 251, and 245
amino acids long with apparent molecular weights by SDS/
PAGE of 36,000, 31,000, and 31,000, respectively (4).
To study the localization and possible function of the
brain-specific TM isoforms, we have generated an isoform-
specific antibody. Our data indicate that expression of exon
9c in the a-TM gene is limited to neurons and is develop-
mentally regulated.
MATERIALS AND METHODS
Neuronal and Glial Cultures. Cultures from 16-day Spra-
gue-Dawley rat embryos were established from the midbrain
as described (19) and in a similat way from the prosenceph-
alon. Glial cultures were made from the primary cultures by
adding epidermal growth factor (Collaborative Research, 10
ng/ml), followed by trypsin treatment after 9 days and
replating on uncoated dishes in Dulbecco's modified Eagle's
medium/15% (vol/vol) fetal calf serum.
Development of Anti-rTM9c, an Antibody Against an Epi-
tope in Exon 9c. The peptide CSH085 (Cys-Tyr-His-Gln-Leu-
Glu-Gln-Asn-Arg-Arg-Leu-Thr-Asn-Glu-Leu-Lys-Leu-Ala-
Leu-Asn-Glu-Asp) representing .the amino acid sequence of
brain-specific exon 9c of the a-TM gene (Fig. 1), with the
exception of the first Cys that was used for coupling, was
coupled to keyhole limpet hemocyanin as described (20). The
resulting polyclonal rabbit serum was affinity-purified (21).
Immunoblot Analysis. Protein for immunoblot analysis was
prepared by homogenizing 0.25 g of tissue in 1 ml of sample
buffer [60 mM Tris*HCI, pH 6.8/2% (wt/vol) SDS/0.1 M
dithiothreitol] using a 20-gauge 1Y2 inch (1 inch = 2.54 cm)
syringe needle, followed by boiling and centrifugation. Pro-
tein was quantitated in sample buffer using a modification of
the Bradford assay (Bio-Rad) (22). Western blot analysis was
performed as described (20) using the ECL system (Amer-
sham).
Immunocytochemistry of Primary Neuronal and Glial Cul-
tures. Immunocytochemistry was performed as described
(19). Primary antibodies were PHF-1, which recognized tau
in rats (a gift from S. Greenberg, Burke Medical Research
Institute, White Plains, NY), anti-glial fibrillary acidic pro-
tein (GFAP), and anti-neurofilament (heavy, medium, and
light chains) from Boehringer Mannheim. They were visual-
ized using fluorescein-conjugated anti-mouse IgG or biotiny-
lated anti-rabbit immunoglobulin (Amersham) and streptavi-
din-conjugated tetramethylrhodamine (Molecular Probes).
RNA Isolation and PCR Analysis. RNA from tissue was
isolated using the hot phenol/guadinium salt method (23).
The sequences of the oligonucleotides (5' -) 3') were as
follows: AS1B01, ATGGCGGGTAGCAGCTCGCTGG;
AS1A01, AAGAAGATGCAGATGCTGAAGCTC; AA501,
CGTCTCGATGATGACCAGCTTAC; AS301, ACAGCTC-
Abbreviations: TM, tropomyosin; GFAP, glial acid fibrillary protein;
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FIG. 1. Schematic representation of the organization of the rat a-TM gene and two (TMBr-1 and TMBr-3) of its nine associated mRNA
products. Exons are represented as boxes and introns are represented as lines as described (4). Exon-specific oligodeoxynucleotides AS1BO1,
AS1AO1, AA9CO1, and AA501 were used for PCR analyses. Oligodeoxynucleotide AS301 was used for Southern blot analysis. All
oligodeoxynucleotides are shown below their corresponding exons. The peptide sequence that was used to raise the rabbit polyclonal antibody
is indicated above exon 9c in the TMBr-1 mRNA.
TACAGAAGCTGGAG (Fig. 1). PCRs were essentially per-
formed as described (16).
RESULTS
Anti-rTM9c Specifically Recognizes an Epitope Contained in
Exon 9c in TMBr-l and TMBr-3. To determine the specificity
of the anti-rTM9c antibody, we performed Western blot
analysis with protein from various brain regions and other
tissues (Fig. 2). Two bands corresponding to TMBr-1 and
TMBr-3 were detected by anti-rTM9c in protein samples
from brain (Fig. 2A). The antibody did not exhibit any cross
reactivity with TMs in liver, kidney, or skeletal muscle. A
parallel blot probed with the TM311 antibody (Fig. 2B)
showed that the TM311 antibody detected additional TM
isoforms in samples that showed no reaction with anti-
rTM9c. The TM311 antibody recognized protein sequences
encoded by exon la and thus TM311 did not react with
TMBr-3 but did react with TMBr-1 and other isoforms. These
results demonstrate that anti-rTM9c is specific for TMBr-1
and TMBr-3.
TMBr-l and TMBr-3 Have Different Regional Distributions
in Adult Rat Brain. To determine the relative distributions of
TMBr-1 and TMBr-3 throughout the brain, we dissected rat
brains and analyzed their expression patterns using the
Western blot technique. TMBr-3 immunoreactivity was de-
tected in essentially equal amounts throughout the adult rat
brain (Fig. 2). In contrast, the signal representing the pres-
ence of TMBr-1 was weaker than that for TMBr-3 and,
furthermore, the signal for TMBr-1 was relatively stronger in
cortex, hippocampus, olfactory bulb, striatum, and thalamus
than in the midbrain, where it was hardly detectable. TMBr-1
was detectable in the brainstem and cerebellum only when
the filters were exposed =10 times longer. TMBr-1 and
TMBr-3 differ at their N-terminal regions due to the use of
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two promoters (Fig. 1). To analyze the distribution of other
TM isoforms throughout the brain, we probed the protein
samples with the TM311 antibody (Fig. 2B). In addition, this
antibody also recognizes sequences contained within the
/-TM gene and the a-TM gene. The isoforms recognized by
the TM311 antibody give rise to three bands on a Western
blot, termed TM-A, TM-B, and TM-C. In brain tissue, TM-A
corresponded to TMBr-1 and fibroblast TM-2 (apparent Mr =
36,000), whereas TM-B corresponded to smooth muscle
a-TM, and TM-C corresponded to smooth muscle ,-TM. The
three isoforms TM-A, TM-B, and TM-C could be detected in
all brain areas, indicating that the promoter associated with
the use of exon la is active in brain areas that do not strongly
express TMBr-1.
TMBr-l anid TMBr-3 Are Expressed at Different Times in
Development. The expression of TMBr-1 and TMBr-3 during
development was examined by Western blot analysis (Fig. 3).
TMBr-3 was detected as early as embryonic day 16 (E16). In
contrast, TMBr-1 was detected at postnatal day 20 (P20). A
band corresponding to TMBr-1 could not be detected in
earlier stages, even when the filters were exposed 10 times
longer. The same filter probed with the antibody TM311
revealed that the expression of other TM isoforms decreased
during development whereas the relative levels of the brain-
specific isoforms increased (Fig. 3B). It is worth noting that
previous studies of the a-TM gene in rat brain using RNA
analysis showed thatmRNA expressed from this gene peaked
at a time soon after birth (24, 25). Our data demonstrate that
the amount of TMBr-1 and TMBr-3 protein increases post-
natally and remains constant after 20 days. The observed
peak in postnatal RNA expression appears to correspond to
the postnatal increase in protein. Since TMBr-1 and TMBr-3
are transcribed from two promoters, the differences in the
developmental expression of these isoforms could be due to
differential regulation of the promoters (Fig. 1). To address
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FIG. 2. Distribution of the brain-specific isoforms TMBr-1 and TMBr-3 in rat brain. Equal amounts of protein (15 ,ug) from various brain
regions, liver, skeletal muscle, and kidney were analyzed. (A) The blot was probed with anti-rTM9c. The arrows indicate the position of TMBr-l
and TMBr-3. (B) A parallel blot was probed with the Sigma TM311 antibody. The arrows indicate the position of three immunoreactive bands
indicated TM-A, TM-B, and TM-C.
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FIG. 3. Expression of the brain-specific a-TM isoforms TMBr-1 and TMBr-3 at different developmental stages. (A) Western blot analysis
of equal amounts of protein (15 pg) using anti-rTM9c. Protein was prepared from whole embryos at E8-E12 and from whole brains at E13-E19,
6-30 days after birth (P6-P30), and 3 months (adult). (B) The filter in A was reprobed using the Sigma TM311 antibody. The arrows indicate
the position of three immunoreactive bands indicated TM-A, TM-B, and TM-C.
this question, we used PCR to analyze RNA isolated from
brain in different developmental stages (Fig. 4). By using this
analysis, RNA generated from the la and lb promoter could
be detected at E8 and E10, respectively, in total brain. For
both promoters, this is earlier than the expression ofexon 9c,
which occurs at E16 (Fig. 3). This indicates that both pro-
moters are active before the exon 9c of the a-TM gene is
expressed and demonstrates that the differences in expres-
sion of TMBr-l and TMBr-3 are likely regulated at the level
of alternative RNA splicing.
Expression of Exon 9c Is Restricted to Neurons. We have
previously demonstrated (4) by RNase protection analysis
that isoforms TMBr-1, TMBr-2, and TMBr-3 are brain-
specific. To determine which cell types express TMBr-1 and
TMBr-3, we performed immunocytochemistry with the anti-
rTM9c antibody on primary neuronal and glial cultures.
Although in primary neuronal cultures the presence of glial
elements, mostly consisting of astrocytes, was minimal, we
distinguished astrocytes from neurons by staining them with
an antibody to GFAP, a cytoskeletal protein found only in
astrocytes (26). The identity of neurons was confirmed with
antibodies to tau and neurofilament, both constituents of the
neuronal cytoskeleton. Exon 9c immunoreactivity was de-
tected in all neurons (Fig. 5 A and B). Double labeling for the
neuronal markers tau and neurofilament revealed correspon-
dence with the exon 9c immunoreactive population. Some
cells that stained brightly with anti-rTM9c stained poorly
with tau and neurofilament, which is probably due to differ-
ent developmental regulation. The staining pattern obtained
with the anti-rTM9c could be blocked by preabsorbing the
antibody with recombinant TMBr-1 (Fig. SC). In addition,
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FIG. 4. PCR analysis of the use of the a-TM gene exon la and lb
promoters during development in brain. The various PCR products
generated by use of the la and lb promoters are indicated. Total
RNA (1 /&g) was reverse-transcribed using the AA501 primer and
amplified using a combination ofASlAOl/AA50l or ASlBOl/AA50l
(Fig. 1). Twenty eight cycles (1 min at 94°C, 45 sec at 56°C, and 2 min
at 72°C) were used. The PCR products were analyzed using a
Southern blot of the products probed with 32P-end-labeled AS301.
Mix, PCR was performed without adding nucleic acid; no RT, PCR
was performed using adult RNA without reverse transcription as a
template; pBr322 Msp I, Msp I digest of pBr322 DNA.
immunocytochemistry was performed on a mixed glia/
neuronal culture using both anti-rTM9c and antibody to
GFAP. We did not observe astrocyte-specific GFAP and
exon 9c immunoreactivity in the same cell (Fig. 5 F-H). The
specificity of anti-rTM9c for neurons was further confirmed
by Western blot analysis that detected a protein band corre-
sponding to TMBr-3 in cortical and mesoncephalic cultures
but not in glial cultures (Fig. 6A). In contrast, GFAP staining
was readily apparent in lysates prepared from glial and
cortical cultures (Fig. 6B). Collectively these studies dem-
onstrate expression of exon 9c is restricted to neurons in
cultures of embryonic rat brain. Furthermore, the lack of
TMBr-1 detected in the primary neuronal cultures derived
from embryonic brain (Fig. 6) is in agreement with the late
developmental expression pattern of this isoform (Fig. 3).
Intracellular Localization of TMBr-3. To investigate
whether the functional significance of the brain-specific iso-
forms may be related to differences in their intracellular
localization, immunofluorescence microscopy was per-
formed using the anti-rTM9c antibody. Although this anti-
body would recognize both TMBr-1 and TMBr-3, the cells
used in these studies notably only express TMBr-3 (Fig. 6).
TMBr-3 was located mainly in the cell body but was also
detected in the processes (Fig. 5 A, E, F, and H). In addition,
in agreement with previous studies ofthe distribution of actin
in neurons, the staining pattern of TMBr-3 appeared diffuse
and we were unable to observe microfilament bundles or
stress fibers using the anti-rTM9c antibody (27, 28).
DISCUSSION
Developmental Regulation of TMBr-1 and TMBr-3. The
different regional and temporal patterns of expression of
TMBr-1 and TMBr-3 that we demonstrated here raise two
important questions. (i) What are the mechanisms responsi-
ble for the differential expression of these isoforms from the
a-TM gene, and (ii) what is the functional significance of
these isoforms in the nervous system? Since these isoforms
both contain exon 9c, it remains to be determined whether
these isoforms are coexpressed in the same cell or in distinct
cell types. Although the promoters for TMBr-1 and TMBr-3
are being transcribed early in development (Fig. 4), we were
not able to determine whether both promoters are active in
the same cell. Thus, there are two possibilities for regulation
of the neuron-specific splicing event that uses exon 9c. One
possibility is that the exon la and lb promoters are used in
different neurons and that the splicing of exon 9c is indepen-
dent of the promoter. The other possibility is that both
promoters are active in the same neuron and the splicing of
exon 9c is influenced by events associated with transcription
at the 5' end of the pre-mRNA (e.g., giving rise to TMBr-1 in
hippocampal neurons but suppressing the use of exon 9c in a
pre-mRNA created by the exon la promoter in neurons of the
Cell Biology: Stamm et al.
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FIG. 5. Neuron-specific expression of exon 9c. Primary cultures from mesencephalon (A-D) or cortex (E-H) were made from E16 embryos
and stained after 9 days ofculture. Staining with anti-rTM9c was detected using rhodamine-conjugated antibody; all other antibodies were visualized
using fluorescein-conjugated antibody, as indicated. (Bars = 20 ,um.) (A and B) Exon 9c is expressed in all neurons. (A) Detection of anti-rTM9c
immunoreactivity. (B) Same field stained using a mixture of anti-tau and anti-neurofilament antibodies. (C-E) Anti-rTM9c immunoreactivity can
be blocked by preabsorbtion with TMBr-1. (C) The anti-rTM9c antibody was preabsorbed with recombinant TMBr-1 before staining the culture.
(D) The same field stained with anti-tau antibody. (E) Higher magnification of neurons stained with anti-rTM9c. (F-H) Anti-rTM9c stains neurons
and not glia. Cells were stained with anti-rTM9c (F) and with GFAP (G). (H) Field in F and G shown in a double exposure.
cerebellum). In this regard it is interesting to note that the
3-kb mRNA containing exon 9c does not contain sequences
from exon la and appears to encode exclusively TMBr-3 (24).
Similarly, the 1.8-kb mRNA containing exon 9c and exon la
appears to encode TMBr-1 (24).
Expression of Exon 9c Is Specific for Neurons. In primary
cultures of neurons and glia, we found that the use of exon 9c
was restricted to neurons (Figs. 5 and 6). It is worth noting
that we were unable to detect the expression ofTMBr-1 in the
primary cultures used in these studies. Since these cells were
derived from embryonic brain, we did not expect to detect
TMBr-1 because TMBr-1 was only expressed >2 weeks after
birth. Furthermore, although we could not detect TMBr-1 in
neuronal cultures, the absence of detectable TMBr-3 in glial
cultures and the expression pattern of these isoforms in adult
brain strongly suggests that both of these isoforms are
specific to neurons. This specificity is in agreement with
recent studies in PC12 cells demonstrating that expression of
mRNA for TMBr-1 and TMBr-3 was concomitant with neu-
ronal differentiation (24). Since the expression of these
isoforms in PC12 cells was found to be temporally associated
with neurite extension, it was hypothesized that these iso-
forms will be localized to dendritic spines and synapses
where they would function in the establishment and mainte-
nance of these structures (24). While we cannot rule out this
possibility for TMBr-1, TMBr-3 was detected in the cell body
as well as in the neuritic processes extending from it (Fig. 5).
This staining pattern was consistently observed in cultures
derived from midbrain and cortex and was examined at early
and later time points in culture. The presence of immunore-
activity throughout the cell leads to the suggestion that
TMBr-3 plays a more general role in neuronal cell structure.
Functions ofTMBr-1 and TMBr-3. At present the functions
of TMBr-1 and TMBr-3 are not known, but their expression
pattern suggests a specialized role in the nervous system. The
developmental study of neuron-specific TM expression pre-
sented here indicates that TMBr-3 and TMBr-1 are expressed
relatively late during embryonic and neonatal development,
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FIG. 6. Western blot analysis of TMBr-1 and TMBr-3 in glial and
neuronal cultures. Lysates from astrocyte cultures (lanes AC),
serum-free glia culture (lanes GCI), glia culture in the presence of
fetal calf serum (lanes GCII), neuronal cultures from cortex (lanes
CC) and 'mesencephalon (lanes MC), and cortex (lanes Cor) and
hippocampus (lanes Hip) from adult rat brain were analyzed on a
Western blot using anti-rTM9c (A) and anti-GFAP (B).
respectively, and remain at a constant leve'l in the adult.
Furthermore, when the expression of TMBr-1 in different
areas of the brain is compared with other high molecular
weight TMs that do not contain exon 9c, areas expressing
high levels of TMBr-1 also express high levels of other TMs
(Fig. 2). Both the developmental time course and the distri-
bution indicate a replacement of nonbrain TM forms reflect-
ing special positional or developmental needs of the neuronal
cytoskeleton. The increase in expression of the brain-specif'ic
isoforms of TMs is coincident with processes of differentia-
tion and maturation of the neuronal population. TMs are
known to be associated with filamentous actin in both muscle
and nonmuscle cell types. In neurons, actin filaments are
thought to play a role in motile processes (2). Perhaps
TMBr-1 and TMBr-3 play a role in process outgrowth, the
formation of dendritic spines, and/or synapse formation, as
TMs have been shown to be present in all of these structures
(2). It is interesting to note that TMBr-1 has the strongest
expression in areas of the brain thought to have the greatest
plasticity after birth (5). The ratio of filamentous actin to
globular actin has been shown to correlate with changes in
visual cortical plasticity (29). In normal rats the amount of
filamentous actin has been shown to be regulated by the
amount of TM present. Furthermore, the potentially weaker
actin binding properties of TMBr-1 and TMBr-3 (4) might
allow for dynamic cytoskeletal changes and thus allow for
continued plasticity in the adult brain. Finally, recent findings
that the expression of TM is changed in some neurodegen-
erative diseases, such as Parkinson and Alzheimer disease
(30) and i4n astrocyte tranisformation (31), furthermore, s'ug-
gests the importance of different TM isoforms in the brain.
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